Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People

NCT05536440

CompletedPhase 1

Sponsor: Pfizer

Conditions: Healthy

Interventions: PF-07261271, Placebo

Countries: United States

The purpose of this clinical trial is to learn about the safety and effects of the study medicine PF-07261271 for the potential treatment of Inflammatory Bowel Disease.

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Healthy individuals as determined by medical evaluation
* Body mass index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight \>50 kg (110 lb).

Exclusion Criteria:

* Clinically significant medical conditions
* History of HIV infection, hepatitis B, or hepatitis C
* BP ≥140 mm Hg (systolic) or ≥90 mm Hg (diastolic)
* Clinically relevant ECG abnormalities
* Previous study drug administration within 30 days or 5 half-lives of first planned dose
* History of drug/alcohol abuse or \>20 cigarettes/day
Locations (4)
  • Lake Forest, California, United States
  • Tustin, California, United States
  • Eatontown, New Jersey, United States
  • Salt Lake City, Utah, United States